CellonTech

CellonTech, a subsidiary of SC Engineering, broke ground on a new advanced manufacturing facility for biocolagen medical devices in Namyangju, South Korea. The plant will have a total floor area of 16,531 m² and is expected to start production by end of 2026, with a total investment of 55 billion KRW.

Cellontech, a subsidiary of SC Engineering, signed a supply contract with China's Just Medical Devices (Tianjin) for the joint cartilage regenerative treatment device 'CartiFill'. The contract guarantees a minimum order quantity of $21 million over five years.

CellonTech, a subsidiary of SC Engineering, signed a supply agreement with Chinese company Just Medical Device for its CartiFill joint cartilage regeneration medical device. The contract guarantees a minimum order quantity of $21 million (approx. KRW 29 billion) over five years.